Literature DB >> 34356793

MCR Expression Conferring Varied Fitness Costs on Host Bacteria and Affecting Bacteria Virulence.

Wan Li1, Zhihai Liu2,3, Wenjuan Yin4, Lu Yang1, Lu Qiao1, Shikai Song1, Zhuoren Ling1, Ruicheng Zheng1, Congming Wu1, Yang Wang1, Jianzhong Shen1.   

Abstract

Since the first report of the plasmid-mediated, colistin-resistant gene, mcr-1, nine mcr genes and their subvariants have been identified. The spreading scope of mcr-1~10 varies greatly, suggesting that mcr-1~10 may have different evolutionary advantages. Depending on MCR family phylogeny, mcr-6 is highly similar to mcr-1 and -2, and mcr-7~10 are highly similar to mcr-3 and -4. We compared the expression effects of MCR-1~5 on bacteria of common physiological background. The MCR-1-expressing strain showed better growth than did MCR-2~5-expressing strains in the presence of colistin. LIVE/DEAD staining analysis revealed that MCR-3~5 expression exerted more severe fitness burdens on bacteria than did MCR-1 and -2. Bacteria expressing MCRs except MCR-2 showed enhanced virulence with increased epithelial penetration ability determined by trans-well model (p < 0.05). Enhanced virulence was also observed in the Galleria mellonella model, which may have resulted from bacterial membrane damage and different levels of lipopolysaccharide (LPS) release due to MCR expression. Collectively, MCR-1-expressing strain showed the best survival advantage of MCR-1~5-expressing strains, which may partly explain the worldwide distribution of mcr-1. Our results suggested that MCR expression may cause increased bacterial virulence, which is alarming, and further attention will be needed to focus on the control of infectious diseases caused by mcr-carrying pathogens.

Entities:  

Keywords:  fitness cost; mcr-1~5; prevalence; virulence

Year:  2021        PMID: 34356793     DOI: 10.3390/antibiotics10070872

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  4 in total

1.  Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus.

Authors:  Yaowen Li; Yu Peng; Na Zhang; Huiping Liu; Jun Mao; Yisong Yan; Shuaishuai Wang; Guang Yang; Yanyan Liu; Jiabin Li; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2022-08-30       Impact factor: 4.177

2.  Large-Scale Analysis of Fitness Cost of tet(X4)-Positive Plasmids in Escherichia coli.

Authors:  Feifei Tang; Wenhui Cai; Lijie Jiang; Zhiqiang Wang; Yuan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-03       Impact factor: 6.073

3.  Multicentre evaluation of a selective isolation protocol for detection of mcr-positive E. coli and Salmonella spp. in food-producing animals and meat.

Authors:  Agnès Perrin-Guyomard; Sophie A Granier; Jannice Schau Slettemeås; Muna Anjum; Luke Randall; Manal AbuOun; Natalie Pauly; Alexandra Irrgang; Jens Andre Hammerl; Jette Sejer Kjeldgaard; Anette Hammerum; Alessia Franco; Magdalena Skarżyńska; Ewelina Kamińska; Dariusz Wasyl; Cindy Dierikx; Stefan Börjesson; Yvon Geurts; Marisa Haenni; Kees Veldman
Journal:  Lett Appl Microbiol       Date:  2022-04-21       Impact factor: 2.813

4.  Colistin Resistance Mechanisms in Human Salmonella&nbsp;enterica Strains Isolated by the National Surveillance Enter-Net Italia (2016-2018).

Authors:  Daniela Fortini; Slawomir Owczarek; Anna Maria Dionisi; Claudia Lucarelli; Sergio Arena; Alessandra Carattoli; Laura Villa; Aurora García-Fernández
Journal:  Antibiotics (Basel)       Date:  2022-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.